Ocata Therapeutics Inc fka OCAT

[farviewhill]

That's surely my observation as well.
This is a totally inappropriate place to 'release' new news.
The presentation could very well be new and/or expanded information for those in attendance as it so often is, but that's the reason interested parties attend these multi-presentation program conferences.

What makes this special, if you will, is that the Piper Jaffray conference is a prestigious, invitation only conference for companies to expand their latest information to participants, who come from a variety of venues, including perspective JV pharmas and brokerage firm analysts, etc.
The conjecture is that the Piper Jaffray analyst there may use this presentation as a 'springboard' for a possible initial coverage of OCATA Therapeutics. They would be a second firm, if so, as Maxim Securities has had a buy recommendation on OCATA for awhile now.